Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3091 AL 3105

Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia

García-García R, Calleja-Hernández MÁ.

Eur J Hosp Pharm. 2022 May;29(3):145-150. doi: 10.1136/ejhpharm-2019-002106. Epub 2020 Jul 28.

The Effects of a Recollection-Based Occupational Therapy Program of Alzheimer's Disease: A Randomized Controlled Trial

Kim D.

Occup Ther Int. 2020 Jul 30;2020:6305727. doi: 10.1155/2020/6305727. eCollection 2020.

Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond

Koola MM.

Psychiatry Res. 2020 Nov;293:113409. doi: 10.1016/j.psychres.2020.113409. Epub 2020 Aug 18.

Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study

Padala PR, Boozer EM, Lensing SY, Parkes CM, Hunter CR, Dennis RA, Caceda R, Padala KP.

J Alzheimers Dis. 2020;77(4):1483-1493. doi: 10.3233/JAD-200640.

Can Alzheimer's Disease Be Prevented? First Evidence from Spinal Stimulation Efficacy on Executive Functions

Pisano F, Caltagirone C, Satriano F, Perri R, Fadda L, Marangolo P.

J Alzheimers Dis. 2020;77(4):1755-1764. doi: 10.3233/JAD-200695.

A phase II randomized trial of sodium oligomannate in Alzheimer's dementia

Wang T, Kuang W, Chen W, Xu W, Zhang L, Li Y, Li H, Peng Y, Chen Y, Wang B, Xiao J, Li H, Yan C, Du Y, Tang M, He Z, Chen H, Li W, Lin H, Shi S, Bi J, Zhou H, Cheng Y, Gao X, Guan Y, Huang Q, Chen K, Xin X, Ding J, Geng M, Xiao S.

Alzheimers Res Ther. 2020 Sep 14;12(1):110. doi: 10.1186/s13195-020-00678-3.

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia

Scuteri D, Vulnera M, Piro B, Bossio RB, Morrone LA, Sandrini G, Tamburin S, Tonin P, Bagetta G, Corasaniti MT.

Eur J Clin Pharmacol. 2021 Feb;77(2):241-249. doi: 10.1007/s00228-020-02995-w. Epub 2020 Sep 15.

D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care

Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Tan Z, Evertson L, Bass D, Weitzman L, Carnie M, Wilson N, Araujo K, Charpentier P, Meng C, Greene EJ, Dziura J, Liu J, Unger E, Yang M, Currie K, Lenoir KM, Green AS, Abraham S, Vernon A, Samper-Ternent R, Raji M, Hirst RM, Galloway R, Finney GR, Ladd I, Rahm AK, Borek P, Peduzzi P.

J Am Geriatr Soc. 2020 Nov;68(11):2492-2499. doi: 10.1111/jgs.16862. Epub 2020 Oct 6.

The search for Alzheimer disease therapeutics - same targets, better trials?

Rafii MS, Aisen PS.

Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.

Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil

Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.

Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.

The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial

Delrieu J, Voisin T, Saint-Aubert L, Carrie I, Cantet C, Vellas B, Payoux P, Andrieu S.

Alzheimers Res Ther. 2020 Oct 19;12(1):134. doi: 10.1186/s13195-020-00683-6.

Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review

Muñoz-Jiménez M, Zaarkti A, García-Arnés JA, García-Casares N.

Dement Geriatr Cogn Disord. 2020;49(5):423-434. doi: 10.1159/000510677. Epub 2020 Oct 20.

Vitamins in Alzheimer's Disease-Review of the Latest Reports

Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, Socha K.

Nutrients. 2020 Nov 11;12(11):3458. doi: 10.3390/nu12113458.

Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease

Chauhan PS, Yadav D, Koul B, Mohanta YK, Jin JO.

Curr Drug Metab. 2020;21(14):1144-1151. doi: 10.2174/1389200221666201124140518.

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain

Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.

Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias